TITLE

Mergers & Acquisitions

AUTHOR(S)
Simpson, Wayne A.
PUB. DATE
May 2006
SOURCE
Enterprise/Salt Lake City;5/8/2006, Vol. 35 Issue 44, p6
SOURCE TYPE
Periodical
DOC. TYPE
Editorial
ABSTRACT
The author discusses issues related to the sale of business enterprises. He argues that deciding whether to sell a business enterprise is a difficult one and raises several questions on the part of a business owner. The reasons for selling a business as well as the reasons not to sell are also discussed. Pieces of advice are presented when planning to sell a business.
ACCESSION #
20874417

 

Related Articles

  • Buyer to keep McNulty trading.  // Professional Engineering;5/11/2005, Vol. 18 Issue 9, p12 

    The article reports that administrators have found a buyer for Tyneside shipyard McNulty Offshore Contractors, which was pushed into administration last month following a contractual dispute. The sale of the business and assets of the firm to Aberdeen-based Consafe saves 45 jobs and enables...

  • Sasol mulls divestment of alkylates.  // European Chemical News;9/15/2003, Vol. 79 Issue 2068, p9 

    Reports the plans of chemical company Sasol to divest its alkylates business in 2003. Factor that influenced the disinvestment plan; Earnings expected from the move; Financial performance of the other business units of Sasol.

  • LUBRIZOL TO SELL DRUG INGREDIENTS BIZ. Bennett, David // Crain's Cleveland Business;4/3/2006, Vol. 27 Issue 14, p1 

    The article reports on the sale of Lubrizol Corp.'s pharmaceutical ingredient and compounds business, to a German private equity firm. Terms weren't disclosed. It would be the fifth divestiture since Wickliffe-based Lubrizol announced its intent to sell noncore businesses.

  • UCB Dumps 50+ Programs in $667M Deal with GSK.  // BioWorld Today;1/26/2009, Vol. 20 Issue 15, p2 

    The article reports on the decision of UCB SA to divest its smaller business operations, reaching a deal to sell more than 50 such programs to GlaxoSmithKline PLC for 515 million euro. Included in the acquisition deal are UCB operations in the Far East, Middle East, Latin America and Africa. UCB...

  • Degussa Puts Food Ingredients Business Up for Sale. Alperowicz, Natasha // Chemical Week;10/20/2004, Vol. 166 Issue 34, p19 

    Reports on the plan of Degussa to sell its food ingredients business. Reason for selling Degussa's food ingredient business; Businesses and entities that comprise the food ingredients operation; Efforts made by Degussa to expand its food ingredient business; Potential buyers of the business.

  • Rhodia managers disclose more refinancing hurdles. Beacham, Will // European Chemical News;3/12004, Vol. 80 Issue 2089, p6 

    Reports that Rhodia must achieve €400 million in gains from its divestment programme by June 30 2004 to satisfy its creditor banks according to a filing with the U.S. Securities and Exchange Commission. Reason behind the launch of the disposable program in 2003; Condition of the disposal...

  • Rhodia near end of unit sales. Beacham, Will // European Chemical News;6/14/2004, Vol. 80 Issue 2104, p7 

    Reports that divestment of Rhodia's phosphate specialties business in the U.S. is in its final stages as of June 2004. Value of divestments achieved by the company since the beginning of 2004; Sale of its food ingredients business to Denmark's Danisco; Total annual sales of Rhodia's specialty...

  • Aventis Aims to Delay Sale of Rhodia Stake. Young, Ian // Chemical Week;11/12/2003, Vol. 165 Issue 41, p19 

    Reports on the plan of Aventis to delay the deadline for the divestment of most of its stake in Rhodia. Antitrust condition imposed on Aventis; Objective of Aventis in delaying the deadline; Impact of the sale of Aventis' stake on Rhodia; Details of the senior management team of Rhodia.

  • SDC Worldwide Mergers & Acquisitions.  // Mergers & Acquisitions Report;6/21/2004, Vol. 17 Issue 25, p7 

    Provides information on several worldwide mergers and acquisitions as of June 21, 2004. Summary of U.S. public merger activity greater than $50 million; Private targets greater than $50 million; Divestitures greater than $50 million.

Share

Read the Article

Other Topics